| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant protein derived from Klebsiella pneumoniae P40 protein; DNA sequence; use in vaccine formulation and in genetic immunization against e.g. respiratory-syncytial virus or hepatitis B virus infection
|
|
|
1996
|
14 |
12 |
p. 1176-
1 p.
|
article
|
| 2 |
A mixed gamma model for regression analyses of quantitative assay data
|
Moulton, Lawrence H.
|
|
1996
|
14 |
12 |
p. 1154-1158
5 p.
|
article
|
| 3 |
An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep
|
Kabeya, Hidenori
|
|
1996
|
14 |
12 |
p. 1118-1122
5 p.
|
article
|
| 4 |
An inactivated avian polyomavirus vaccine is safe and immunogenic in various Psittaciformes
|
Ritchie, Branson W.
|
|
1996
|
14 |
12 |
p. 1103-1107
5 p.
|
article
|
| 5 |
Calendar
|
|
|
1996
|
14 |
12 |
p. 1177-
1 p.
|
article
|
| 6 |
Enhancing immunogenicity by coupling immunogen to serum albumin binding protein; virus recombinant immunogen and serum albumin binding fusion protein production by vector expression in e.g. Escherichia coli, by surface display, for application as a recombinant vaccine
|
|
|
1996
|
14 |
12 |
p. 1176-
1 p.
|
article
|
| 7 |
Flea serine protease and flea aminopeptidase DNA and protein; recombinant enzyme production by vector expression in host cell, and virus, for application as a recombinant vaccine against e.g. Ctenocephalides felis and Pulex irritans
|
|
|
1996
|
14 |
12 |
p. 1176-
1 p.
|
article
|
| 8 |
Helicobacter pylori and gastroduodenal disorders: new approaches for prevention, diagnosis and treatment
|
Kotloff, Karen L.
|
|
1996
|
14 |
12 |
p. 1174-1175
2 p.
|
article
|
| 9 |
High immunogenicity and good tolerability of a new hepatitis A vaccine candidate
|
Langer, B.C.A.
|
|
1996
|
14 |
12 |
p. 1089-1091
3 p.
|
article
|
| 10 |
Immunogenicity and safety of a new inactivated Hepatitis A Vaccine: a clinical trial with comparison of administration route
|
Fisch, Alain
|
|
1996
|
14 |
12 |
p. 1132-1136
5 p.
|
article
|
| 11 |
Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein
|
Rigby, Mark A.
|
|
1996
|
14 |
12 |
p. 1095-1102
8 p.
|
article
|
| 12 |
Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome
|
Ohishi, Kazue
|
|
1996
|
14 |
12 |
p. 1143-1148
6 p.
|
article
|
| 13 |
Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time
|
Künzel, W.
|
|
1996
|
14 |
12 |
p. 1108-1110
3 p.
|
article
|
| 14 |
Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization
|
Hsu, Shiou-Chih
|
|
1996
|
14 |
12 |
p. 1159-1166
8 p.
|
article
|
| 15 |
Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase
|
Ivanoff, Nathalie
|
|
1996
|
14 |
12 |
p. 1123-1131
9 p.
|
article
|
| 16 |
New fusion proteins comprising a single chain T-cell receptor; chimeric receptor and maltose binding protein affinity tail fusion protein expression; use as an immunosuppressive recombinant vaccine and in monoclonal antibody production
|
|
|
1996
|
14 |
12 |
p. 1176-
1 p.
|
article
|
| 17 |
Oral administration of a bacterial immunomodulator enhances the immune response to cholera toxin
|
Fló, Juan
|
|
1996
|
14 |
12 |
p. 1167-1173
7 p.
|
article
|
| 18 |
Oral application of romurtide, a synthetic muramyl dipeptide derivative, stimulates nonspecific resistance to microbial infections and hematopoiesis in mice
|
Namba, Kenji
|
|
1996
|
14 |
12 |
p. 1149-1153
5 p.
|
article
|
| 19 |
Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers
|
von Specht, Bernd-Ulrich
|
|
1996
|
14 |
12 |
p. 1111-1117
7 p.
|
article
|
| 20 |
Secretion of recombinant hydrophobic peptide analog; respiratory-syncytial virus G-protein peptide analog expression in Escherichia coli, Staphylococcus carnosus or Staphylococcus xylosus, for use as an oral recombinant vaccine
|
|
|
1996
|
14 |
12 |
p. 1176-
1 p.
|
article
|
| 21 |
Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection
|
Nandy, R.K.
|
|
1996
|
14 |
12 |
p. 1137-1142
6 p.
|
article
|
| 22 |
Single-dose hepatitis A vaccination: comparison of different dose levels in adolescents
|
Poovorawan, Yong
|
|
1996
|
14 |
12 |
p. 1092-1094
3 p.
|
article
|
Journal description